AXA IM Alts has raised €1.9 billion of equity to accelerate investments into the Life Sciences sector. The capital raised will primarily be invested through Kadans Science Partner, which will enable Kadans to execute
Our food system is a very complex system that consists of a worldwide network with millions of suppliers, farmers, transporters and factories. This is an energy-consuming system that often has a major impact on
Building the Future episode 2: The hospital of the future will be your own living room The technology that enables physicians to remotely monitor the health of patients is becoming increasingly sophisticated and offers
Less damage to organs and a greater chance of survival after a heart attack. That's the commitment of the Dutch start-up CardiacBooster. Start-up CardiacBooster is developing a small but powerful pump that can pump
Date: Thursday July 1 Programme: 11.00 - 11.55 CEST : Presentation Hezelburcht 12.00 - 13.00 CEST : Discussion personal cases Where: Online This webinar is powered by: Hezelburcht Research and development processes are important
Accelerating the European recovery and sustainable transition through an investment strategy for innovation ecosystems This piece, written by some of IASP's partners including the Joint Research Centre of the European Commission, PlusValue and more,
In the podcast Building the Future various experts discuss how they see the future. Various themes from life sciences, agrifood and high-tech sectors are covered. The unique thing about the podcasts is that the
The Venture Challenge helps starting entrepreneurs in the life sciences to bring their service or product to the market. In a programme of approximately ten weeks, starters receive support in setting up a company
On May 10, the Kadans Connected webinar regarding patents was organized in collaboration with Briskr and EDP. Ard Ellens – Patent Attorney of EDP and Ruben van Heck – Attorney Trainee, EDP gave insight
Access Biotech China - 14 & 15 October 2021 Helping European biotechs develop their China market entry strategy Access Biotech China (ABC) is a new conference and partnering event focused on helping European biotech companies to
